股本结构
单位：万股
| 公告日期 | 2023-08-14 | 2023-05-15 | 2023-03-22 | 2023-01-26 | 2022-11-10 | 2022-08-11 |
|---|---|---|---|---|---|---|
| 证券总股本 | 880.93 | 880.00 | 879.88 | 835.99 | 8359.92 | 8359.92 |
| 普通股本 | 880.93 | 880.00 | 879.88 | 835.99 | 8359.92 | 8359.92 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2023-08-08 | 2023-03-31 | 2023-03-17 | 2023-01-27 | 2022-11-01 | 2022-06-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2023-08-14 | 880.93 | 未披露 | 定期报告 | 2023-08-08 |
| 2023-05-15 | 880.00 | 未披露 |
更多>>
From January 1, 2023 to March 31, 2023
Issuance of common stock as commitment fee for future financing
Issuance of common stock for cash
Fractional shares adjustment due to reverse split
|
2023-03-31 |
| 2023-03-22 | 879.88 | 未披露 | 定期报告 | 2023-03-17 |
| 2023-01-26 | 835.99 | 未披露 |
更多>>
On January 26, 2023, Marker Therapeutics, Inc. (the “Company”) filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “Amendment”) with the Secretary of State of the State of Delaware to effect a one-for-ten (1-for-10) reverse stock split (the “Reverse Stock Split”).
|
2023-01-27 |
| 2022-11-10 | 8359.92 | 未披露 | 定期报告 | 2022-11-01 |
| 2022-08-11 | 8359.92 | 未披露 |
更多>>
From April 1, 2022 to June 30, 2022
Issuance common shares for cash, net
|
2022-06-30 |
| 2022-05-13 | 8359.92 | 未披露 | 定期报告 | 2022-05-01 |
| 2022-05-13 | 8350.00 | 未披露 |
更多>>
From January 1, 2022 to March 31, 2022
Stock-based compensation
|
2022-03-31 |
| 2022-03-17 | 8307.87 | 未披露 | 定期报告 | 2022-03-01 |
| 2022-03-17 | 8310.00 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of common stock for cash (net of offering costs of $3.9 million)
Stock options exercised for cash
Stock-based compensation
|
2021-12-31 |
| 2021-11-10 | 8307.87 | 未披露 | 定期报告 | 2021-11-01 |
| 2021-11-10 | 8310.00 | 未披露 | 定期报告 | 2021-09-30 |
| 2021-08-10 | 8307.87 | 未披露 |
更多>>
From April 1, 2021 to June 30, 2021
Stock options exercised for cash
Stock-based compensation
|
2021-06-30 |
| 2021-05-12 | 8301.39 | 未披露 |
更多>>
From January 1, 2021 to March 31, 2021
Issuance of common stock for cash
|
2021-03-31 |
| 2021-03-16 | 7930.31 | 未披露 |
更多>>
1.Common stock offered by the company 28,572,000 shares.
2.The number of shares of common stock to be outstanding after this offering is based on 50,731,072 shares of common stock outstanding as of December 31, 2020.
|
2021-03-16 |
| 2021-03-11 | 5073.11 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Issuance common stock for cash
Warrants exercised for cash
Issuance of common stock as commitment fee for future financing
Stock-based compensation
|
2020-12-31 |
| 2020-11-09 | 4802.51 | 未披露 |
更多>>
From July 1, 2020 to September 30, 2020
Issuance common stock for cash
|
2020-09-30 |
| 2020-08-10 | 4661.76 | 未披露 |
更多>>
From April 1, 2020 to June 30, 2020
Stock-based compensation
|
2020-06-30 |
| 2020-05-11 | 4653.25 | 未披露 |
更多>>
From December 31, 2019 to March 31, 2020
Warrants exercised for cash
Issuance of common stock as commitment fee for future financing
|
2020-03-31 |
| 2020-03-12 | 4653.25 | 未披露 | 定期报告 | 2020-03-09 |
| 2020-03-02 | 4618.72 | 未披露 | 定期报告 | 2020-02-28 |
| 2020-03-12 | 4572.88 | 未披露 |
更多>>
From December 31, 2018 to December 31, 2019
Stock warrants exercised for cash
Warrants exercised for cash
Stock warrants cashless exercised
Stock-based compensation
|
2019-12-31 |
| 2019-11-12 | 4572.34 | 未披露 | 定期报告 | 2019-11-04 |
| 2019-11-12 | 4570.00 | 未披露 |
更多>>
from July 1, 2019 to September 30, 2019
Stock warrants exercised for cash
Stock warrants cashless exercised
Stock-based compensation
|
2019-09-30 |
| 2019-08-09 | 4567.06 | 未披露 | 定期报告 | 2019-08-05 |
| 2019-08-09 | 4550.00 | 未披露 |
更多>>
From April 1, 2019 to June 30, 2019
Stock-based compensation
|
2019-06-30 |
| 2019-05-10 | 4548.45 | 未披露 | 定期报告 | 2019-05-03 |
| 2019-05-10 | 4550.00 | 未披露 |
更多>>
from January 1, 2019 to March 31, 2019
Stock options exercised for cash
Warrants exercised for cash
Stock-based compensation
|
2019-03-31 |
| 2019-03-28 | 4544.07 | 未披露 | 定期报告 | 2019-03-18 |
| 2019-03-15 | 4546.77 | 未披露 | 定期报告 | 2019-02-28 |
| 2019-03-15 | 4544.07 | 未披露 |
更多>>
From December 31, 2017 to December 31, 2018
Issuance of common stock for research and development intellectual property
Issuance of common stock and warrants in private placement
Stock options exercised for cash
Stock warrants exercised for cash
Stock warrants cashless exercised
Stock-based compensation
Repurchase of common stock to pay for employee withholding taxes
|
2018-12-31 |
| 2018-11-13 | 4537.07 | 未披露 | 定期报告 | 2018-11-08 |
| 2018-10-17 | 1391.43 | 未披露 | 定期报告 | 2018-10-17 |
| 2018-11-13 | 1384.48 | 未披露 |
更多>>
From January 1, 2018 to September 30, 2018
Issuance of common stock in private placement
Stock options exercised for cash
Stock warrants exercised for cash
Stock warrants cashless exercised
Stock-based compensation
|
2018-09-30 |
| 2018-08-09 | 1371.05 | 未披露 | 定期报告 | 2018-08-02 |
| 2018-08-09 | 1360.00 | 未披露 |
更多>>
From January 1, 2018 to June 30, 2018
Issuance of common stock in private placement
Stock options exercised for cash
Stock warrants exercised for cash
Stock warrants cashless exercised
Stock-based compensation
|
2018-06-30 |
| 2018-05-15 | 1068.45 | 未披露 | 定期报告 | 2018-05-11 |
| 2018-05-15 | 1060.00 | 未披露 |
更多>>
From January 1, 2018 to March 31, 2018
Stock options exercised for cash
Stock-based compensation
|
2018-03-31 |
| 2018-03-23 | 1062.61 | 未披露 | 定期报告 | 2018-03-16 |
| 2018-03-23 | 1060.00 | 未披露 |
更多>>
from December 31, 2016 to December 31, 2017
Common stock and warrants issued in private placement
Exercise of warrants
Stock-based compensation
Repurchase of common stock to pay for employee withholding taxes
|
2017-12-31 |
| 2017-11-14 | 1053.91 | 未披露 | 定期报告 | 2017-11-01 |
| 2017-11-14 | 1050.00 | 未披露 |
更多>>
From January 1, 2017 To September 30, 2017
Common stock and warrants issued in private placement
Exercise of warrants
Stock-based compensation
Repurchase of common stock to pay for employee withholding taxes
|
2017-09-30 |
| 2017-09-20 | 1027.17 | 未披露 | 定期报告 | 2017-09-18 |
| 2017-08-07 | 1015.90 | 未披露 |
更多>>
from January 1, 2017 to June 30, 2017
Common stock and warrants issued in private placement
Exercise of warrants
Stock- based compensation
|
2017-06-30 |
| 2017-05-05 | 847.08 | 未披露 |
更多>>
from January 1, 2017 to March 31, 2017
Stock- based compensation
|
2017-03-31 |
| 2017-03-14 | 843.92 | 未披露 | 定期报告 | 2017-03-13 |
| 2017-03-14 | 842.12 | 未披露 |
更多>>
from December 31, 2015 to December 31, 2016
Issuance of common stock in private placement
Fair value of shares issued as inducement on August 10, 2016
Exercise of stock warrants
Exercise of stock options
Shares issued in debt settlement agreements
Stock- based compensation
On September 13, 2016, the Company’s Board of Directors approved a 1-for-12 reverse stock split of the Company’s authorized and issued and outstanding common stock. The reverse stock split became effective on September 16, 2016.
|
2016-12-31 |
| 2016-12-22 | 839.58 | 未披露 | 定期报告 | 2016-12-15 |
| 2016-11-07 | 837.91 | 未披露 | 定期报告 | 2016-11-02 |
| 2016-11-07 | 839.58 | 未披露 |
更多>>
from December 31, 2015 to September 30, 2016
Issuance of common stock in private placement
Fair value of shares issued as inducement on August 10, 2016
Exercise of warrants
Shares issued in debt settlement agreements
Stock- based compensation
Effective September 16, 2016, the Company effected a one for twelve reverse stock-split of our issued and outstanding common stock and has retroactively adjusted our common shares outstanding, options and warrants amounts outstanding. The Company has presented its share data for and as of all periods presented on this basis. The par value was not adjusted as a result of the one for twelve reverse stock split. All prior period share transactions included in the Company’s stock transactions and balances have been retroactively restated.
|
2016-09-30 |
| 2016-04-14 | 7099.08 | 未披露 | 定期报告 | 2016-04-01 |
| 2016-04-14 | 7055.08 | 未披露 |
更多>>
from December 31, 2014 to December 31, 2015
Accounts payable settled in shares
Private placement (net of finders’ fee)
Exercise of warrants
Shares issued in settlement
Stock- based compensation
|
2015-12-31 |
From January 1, 2023 to March 31, 2023
Issuance of common stock as commitment fee for future financing
Issuance of common stock for cash
Fractional shares adjustment due to reverse split
On January 26, 2023, Marker Therapeutics, Inc. (the “Company”) filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “Amendment”) with the Secretary of State of the State of Delaware to effect a one-for-ten (1-for-10) reverse stock split (the “Reverse Stock Split”).
From April 1, 2022 to June 30, 2022
Issuance common shares for cash, net
From January 1, 2022 to March 31, 2022
Stock-based compensation
From December 31, 2020 to December 31, 2021
Issuance of common stock for cash (net of offering costs of $3.9 million)
Stock options exercised for cash
Stock-based compensation
From April 1, 2021 to June 30, 2021
Stock options exercised for cash
Stock-based compensation
From January 1, 2021 to March 31, 2021
Issuance of common stock for cash
1.Common stock offered by the company 28,572,000 shares.
2.The number of shares of common stock to be outstanding after this offering is based on 50,731,072 shares of common stock outstanding as of December 31, 2020.
From December 31, 2019 to December 31, 2020
Issuance common stock for cash
Warrants exercised for cash
Issuance of common stock as commitment fee for future financing
Stock-based compensation
From July 1, 2020 to September 30, 2020
Issuance common stock for cash
From April 1, 2020 to June 30, 2020
Stock-based compensation
From December 31, 2019 to March 31, 2020
Warrants exercised for cash
Issuance of common stock as commitment fee for future financing
From December 31, 2018 to December 31, 2019
Stock warrants exercised for cash
Warrants exercised for cash
Stock warrants cashless exercised
Stock-based compensation
from July 1, 2019 to September 30, 2019
Stock warrants exercised for cash
Stock warrants cashless exercised
Stock-based compensation
From April 1, 2019 to June 30, 2019
Stock-based compensation
from January 1, 2019 to March 31, 2019
Stock options exercised for cash
Warrants exercised for cash
Stock-based compensation
From December 31, 2017 to December 31, 2018
Issuance of common stock for research and development intellectual property
Issuance of common stock and warrants in private placement
Stock options exercised for cash
Stock warrants exercised for cash
Stock warrants cashless exercised
Stock-based compensation
Repurchase of common stock to pay for employee withholding taxes
From January 1, 2018 to September 30, 2018
Issuance of common stock in private placement
Stock options exercised for cash
Stock warrants exercised for cash
Stock warrants cashless exercised
Stock-based compensation
From January 1, 2018 to June 30, 2018
Issuance of common stock in private placement
Stock options exercised for cash
Stock warrants exercised for cash
Stock warrants cashless exercised
Stock-based compensation
From January 1, 2018 to March 31, 2018
Stock options exercised for cash
Stock-based compensation
from December 31, 2016 to December 31, 2017
Common stock and warrants issued in private placement
Exercise of warrants
Stock-based compensation
Repurchase of common stock to pay for employee withholding taxes
From January 1, 2017 To September 30, 2017
Common stock and warrants issued in private placement
Exercise of warrants
Stock-based compensation
Repurchase of common stock to pay for employee withholding taxes
from January 1, 2017 to June 30, 2017
Common stock and warrants issued in private placement
Exercise of warrants
Stock- based compensation
from January 1, 2017 to March 31, 2017
Stock- based compensation
from December 31, 2015 to December 31, 2016
Issuance of common stock in private placement
Fair value of shares issued as inducement on August 10, 2016
Exercise of stock warrants
Exercise of stock options
Shares issued in debt settlement agreements
Stock- based compensation
On September 13, 2016, the Company’s Board of Directors approved a 1-for-12 reverse stock split of the Company’s authorized and issued and outstanding common stock. The reverse stock split became effective on September 16, 2016.
from December 31, 2015 to September 30, 2016
Issuance of common stock in private placement
Fair value of shares issued as inducement on August 10, 2016
Exercise of warrants
Shares issued in debt settlement agreements
Stock- based compensation
Effective September 16, 2016, the Company effected a one for twelve reverse stock-split of our issued and outstanding common stock and has retroactively adjusted our common shares outstanding, options and warrants amounts outstanding. The Company has presented its share data for and as of all periods presented on this basis. The par value was not adjusted as a result of the one for twelve reverse stock split. All prior period share transactions included in the Company’s stock transactions and balances have been retroactively restated.
from December 31, 2014 to December 31, 2015
Accounts payable settled in shares
Private placement (net of finders’ fee)
Exercise of warrants
Shares issued in settlement
Stock- based compensation